000 | 01455 a2200373 4500 | ||
---|---|---|---|
005 | 20250517004114.0 | ||
264 | 0 | _c20150821 | |
008 | 201508s 0 0 eng d | ||
022 | _a1873-2364 | ||
024 | 7 |
_a10.1016/j.nmd.2014.08.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkada, Akinori | |
245 | 0 | 0 |
_aEfficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report. _h[electronic resource] |
260 |
_bNeuromuscular disorders : NMD _cJan 2015 |
||
300 |
_a70-2 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAutoantibodies |
650 | 0 | 4 |
_aCalcium Channels, P-Type _xblood |
650 | 0 | 4 |
_aCalcium Channels, Q-Type _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _xdiagnosis |
650 | 0 | 4 |
_aMuscle, Skeletal _xphysiopathology |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKoike, Haruki | |
700 | 1 | _aNakamura, Tomohiko | |
700 | 1 | _aMotomura, Masakatu | |
700 | 1 | _aSobue, Gen | |
773 | 0 |
_tNeuromuscular disorders : NMD _gvol. 25 _gno. 1 _gp. 70-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nmd.2014.08.006 _zAvailable from publisher's website |
999 |
_c24399066 _d24399066 |